Transcarent joined the Unicorn Club on January 11, 2022, after raising a $200 million Series C funding round led by Kinnevik and Human Capital, valuing the company at $1.62 billion. The San Francisco-based healthcare technology company delivers an AI-powered employee health benefits platform that guides users through their healthcare journey—connecting them with clinical guidance, virtual and in-person care, and condition-specific programs. With a total of $424 million raised and a $2.2 billion valuation as of May 2024, Transcarent is redefining how employers and employees navigate the healthcare landscape.
Keep reading to explore Transcarent’s business model, funding history, investors, and growth roadmap.
What Is Transcarent and What Does It Do?
Founded in 2018, Transcarent offers a comprehensive digital health platform that integrates care navigation, telehealth, pharmacy, surgery, and chronic condition management into a single, user-friendly interface. Its AI-driven solution empowers employees and their families to make more informed healthcare decisions, without having to navigate the fragmented networks of traditional insurance.
Transcarent’s platform offers 24/7 access to virtual care, personalized recommendations, and transparent cost estimates. Users can manage everything from mental health consultations to cancer care and weight management, ensuring proactive and connected experiences throughout their health journey.
The company’s approach enables self-insured employers to reduce costs while improving employee satisfaction, outcomes, and engagement, positioning Transcarent at the intersection of HRTech and digital health innovation.
How Much Funding Has Transcarent Raised?
- Series C
- Amount Raised: $200M
- Date: January 11, 2022
- Lead Investors: Kinnevik, Human Capital
- Motivation: Expansion of the digital health benefits platform and strategic hires across clinical and product divisions.
- Series D
- Amount Raised: $126M
- Date: May 2, 2024
- Lead Investors: Ally Bridge Group, Geodesic Capital
- Motivation: To accelerate AI integration, enhance virtual care offerings, and scale partnerships with large employers and healthcare providers.
Total Funding Raised: $424M
Current Valuation: $2.2B (as of May 2024)
Latest Funding Round: Series D, May 2024
Key Investors
- Kinnevik
- Swedish investment firm known for backing technology-driven healthcare and consumer services companies.
- Focuses on long-term investments in digital health, fintech, and e-commerce.
- Human Capital
- Early-stage venture capital firm focusing on AI-powered platforms and workforce solutions.
- Invested in Transcarent to advance intelligent automation in healthcare delivery.
- Ally Bridge Group
- Global life science investment firm specializing in late-stage growth capital for biotech and healthcare innovation.
- Geodesic Capital
- Investor focusing on growth-stage U.S. technology firms expanding internationally.
Where Is Transcarent’s Headquarters?
Transcarent is headquartered in San Francisco, California, United States, a global hub for digital health innovation and venture-backed healthcare startups. The company benefits from proximity to world-class health systems, biotech investors, and a robust AI talent ecosystem.
What’s Next for Transcarent?
With a $2.2 billion valuation and a rapidly expanding product suite, Transcarent is focusing on AI-enabled personalized care navigation, expanding its provider network, and launching new modules for chronic disease and women’s health. The company aims to redefine how employers deliver healthcare benefits—transitioning from reactive treatment to proactive, connected care.
Upcoming initiatives include predictive health analytics, enhanced payer integrations, and partnerships with major healthcare systems to expand our reach nationwide. The goal is to make high-quality healthcare accessible, transparent, and cost-effective for millions of employees.
Get Investor & Funding Insights with TexAu
TexAu provides detailed fundraising data on companies like Transcarent. Track investors, analyze healthcare startup trends, and gain competitive insights to drive strategic business decisions.
Sign up for Free on TexAu and unlock real-time investor and funding intelligence.
